Quality is Life — Laos Alliance Pharmaceutical Group

ລາວ/中文/EN

Manufacturing & innovation
Manufacturing Capabilities
Every dosage form we make
Manufacturing Network
Plants & 20 workshops
Research & Development
Labs, ATMP & formulation
Quality & GMP
Standards & traceability
Alliance Stem Cell Centre
Stem-cell, NK & exosome science
Integrated Value Chain
Farm → chemicals → finished
What we make
Every major dosage form, made to one GMP standard
Explore capabilities
NEWSROOM

Manufacturing

Alliance Pharma Group — six-month achievements 2026
Company
1 Jul 2026

A Driving Force in Southeast Asian Pharmaceutical Manufacturing

Alliance’s first-half 2026 highlights, from ASEAN expansion to advanced biopharmaceutical manufacturing.
ALI-TIRZEP (tirzepatide) 2.5 mg / 0.5 mL single-dose pen product packaging
Product news
13 May 2026

ALI-TIRZEP® (tirzepatide) registered in Lao PDR across eight presentations

The Food and Drug Department has issued certificates of drug registration for ALI-TIRZEP® (tirzepatide) in eight presentations — four single-dose and four multi-dose — manufactured by Alliance Pharmaceutical Co., Ltd in Vientiane Capital.
Become a partner
EN·ລາວ·中文